Entries by Mario

Establishment Labs Strengthens Leadership Team with the Appointment of Nicolas Maurer as Chief Commercial Officer

NEW YORK, NY (PRWEB) JUNE 12, 2017 Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation, announced today that Nicolas Maurer has been appointed Chief Commercial Officer effective immediately. Maurer will oversee the company’s commercial sales and marketing initiatives, establishing Motiva Implants® as one […]

Establishment Labs Announces Certification of its Second Facility in Costa Rica

Second manufacturing facility in Costa Rica has received certification and begun shipping units to Europe and around the world. This new site, in combination with the company’s existing facility, extends manufacturing capacity by 4X and enables the company to expand its distribution capability. NEW YORK, NY (PRWEB) JUNE 02, 2017 Establishment Labs, a global medical […]

Establishment Labs Expands Management Team with Key Addition in Quality Assurance and Regulatory Affairs

NEW YORK, NY (PRWEB) MAY 26, 2017 Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation, announced today the expansion of its leadership team with the addition of Alberto Quesada as Vice President of Quality Assurance & Regulatory Affairs. “We are pleased to add […]

Establishment Labs Announces Close of $18M Financing Round

The funding will be used primarily to support the international launch of Motiva Implants® and Puregraft® in new markets NEW YORK, NY (PRWEB) APRIL 17, 2017 Establishment Labs, a global medical device company focused on breast surgery technologies with a strong emphasis on product development and innovation, announced today that it has closed an $18 […]

Establishment Labs Announces Regulatory Clearances in Brazil

Establishment Labs Announces Regulatory Clearances in Brazil NEW YORK, NY (PRWEB) MARCH 31, 2017 Establishment Labs, a global medical device company focused on breast surgery technologies with a strong emphasis on product development and innovation, announced today that it has received regulatory approval from the Brazilian National Health Surveillance Agency (ANVISA) to market Motiva Implants® […]

Establishment Labs Announces Opening of New Medical Device Manufacturing Facility

Investment of $16.5M in the new manufacturing facility will support its growing international market presence NEW YORK, NY (PRWEB) DECEMBER 15, 2016 Establishment Labs, a global medical device company focused on breast implant technologies with a strong emphasis on product development and innovation, announced today the opening of a state of the art silicone medical […]

New Technology by Establishment Labs Results in Increased Safety for Patients Seeking Breast Augmentation

Patient centric innovation is cornerstone of new Safety Campaign NEW YORK, NY (PRWEB) OCTOBER 17, 2016 Establishment Labs, a global medical device company focused on breast implant technologies with a strong emphasis on product development and innovation, today announced the launch of the Motiva Safety Campaign featuring Motiva Implants® with Q Inside Safety Technology™. The […]

Establishment Labs and Puregraft Announce Strategic Partnership

An exclusive international distribution transaction marries advanced breast implants and autologous fat transfers NEW YORK, NY (PRWEB) SEPTEMBER 14, 2016 Establishment Labs, a global medical device company focused on next-generation breast implants and other innovative medical device technologies, announced today that it has entered into an exclusive agreement to distribute Puregraft’s® line of autologous fat […]

Establishment Labs Announces Completion of a $28 Million Financing

NEW YORK, NY (PRWEB) JULY 20, 2016 Establishment Labs, a global medical device company focused on breast implant technologies with a strong emphasis on product development and innovation, announced that existing investors exercised their option to invest an additional $6.84 Million, completing a $28 Million financing. Investors in the financing include Crown Predator Holdings (CPH), JW […]

Establishment Labs Receives Korean Regulatory Approval for Motiva Implants

Establishment Labs, a global medical device company focused on breast implant technologies with a strong emphasis on product development and innovation, announced today that it has received approval from the Korean Food & Drug Administration (KFDA). Establishment Labs also announced a 10 year distribution agreement with Seoul-based Human Wellness Corporation (HWC) to market Motiva Implants® […]